期刊文献+

糖末宁颗粒治疗糖尿病性周围神经病变(气虚络阻证)432例临床研究 被引量:13

Effect of Tangmoning Granule in Treating Diabetic Peripheral Neuropathy with Qi-deficiency and Collateral Stagnation Syndrome:An Observation of 432 Cases
下载PDF
导出
摘要 目的评价糖末宁颗粒治疗糖尿病性周围神经病变(气虚络阻证)的安全性和有效性。方法采用随机、阳性药平行对照、多中心临床试验方法,试验组口服糖末宁颗粒,对照组口服弥可保片,8周为1个疗程。结果糖末宁颗粒对糖尿病性周围神经病变的肌电图疗效的显效率为60.06%,总有效率为68.47%;中医证候疗效的显效率为23.12%,总有效率为90.99%。以15%为非劣效标准,对糖末宁组的肌电图疗效及中医证候疗效进行非劣效性检验,非劣效性检验合格。结论糖末宁颗粒能改善糖尿病性周围神经病变气虚络阻证的病情,同时安全性良好。 Objective To observe the efficacy and safety of Tangmoning Granule (TMG) in treating diabetic peripheral neuropathy with Qi - deficiency and collateral stagnation syndrome. Methods A randomized, positive drug parallel controled, multi -center clinical trial was adopted. The tested group was treated with TMG orally and the control group received Mikebao tablet orally. Treatment course of each group was 8 weeks. Results The marked effective rate and total effective rate on electromyogram was 60. 06 % and 68.47 % respectively in the tested group, and those on TCM Syndrome were 23.12 % and 90.99 % respectively. Non - inferiority test with the criterion of 15 % was conducted on the efficacy of electromyogram and TCM Syndrome, and the result showed statistical significant. Conclusion TMG has good efficacy and safety in treating diabetic peripheral neuropathy with Qi - deficiency and collateral stagnation syndrom.
出处 《中药新药与临床药理》 CAS CSCD 2007年第1期66-69,共4页 Traditional Chinese Drug Research and Clinical Pharmacology
关键词 糖末宁颗粒 糖尿病性周围神经病变 气虚络阻证 临床试验 Tangmoning Granule Diabetic peripheral neuropathy Qi -deficiency and collateral stagnation syndrome Clinical trial
  • 相关文献

参考文献9

  • 1.药品注册管理办法[S].[S].国家药品监督符理局,2002..
  • 2国家食品药品监督管理局.药品临床试验管理规范[S].2003.
  • 3卢祖能 曾庆杏.实用肌电图学[M].北京:人民卫生出版社,2001.338.
  • 4Charles L,Ander AFS.The ponalrestat Study Group:Progression Rates of Diabetic Neuropathy in Placebo Patients in an 18Month Clinical Trial[J].J Diab Comp,1998,12:121-127.
  • 5Nigishi H,Nobuo S,Yukio S,et al.Clinical investigation of Epalrestat,an Aldose Reductase Inhibitor,on Diabetic Neuropathy in Japan:Multicenter Study[J].J Diab Comp,1996,10:168-172.
  • 6Gallai V,Mazzotta G,Montesi S,et al.Effects of uridine in the treatment of diabetic neuropathy:an electrophysiological study[J].Acta Neurol Scand,1992,86:3-7.
  • 7汤晓芙.神经系统疾病临床电生理诊断-肌电图及其它[M].北京:人民军医出版社,2002:124-125.
  • 8ZY/001.61995,中华人民共和国中医药行业标准·中医病证诊断疗效标准[S].
  • 9王镁,张兰,刘雯,于世家.糖末宁提高糖尿病大鼠神经传导速度及镇痛作用的实验研究[J].辽宁中医杂志,2003,30(7):596-597. 被引量:5

二级参考文献4

  • 1Hotta N, et al. Effect of a fructose-rich diet and the aldose reductase inhibitors, (ONO-2235), on the development of diabetic neuropathy streptozotocin-diabetic rats [ J ]. Diabetologia, 1985, 28 :176.
  • 2Cameron NE, Cotter MA. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy[J], Diabetes, 1997, 46 (supple 2):S31.
  • 3于世家.糖末宁治疗糖尿病性周围神经病变临床研究.中国中西医结合杂志,1995,15(7):432-432.
  • 4于世家.糖末宁对糖尿病周围神经病变血浆β-内啡呔水平和神经电生理影响的研究[J].中医药学刊,2002,20(3):270-272. 被引量:24

共引文献21

同被引文献172

引证文献13

二级引证文献108

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部